Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E

The New England Journal of Medicine
E M ReimanD Osborne

Abstract

Variants of the apolipoprotein E allele appear to account for most cases of late-onset Alzheimer's disease, and persons with two copies of the epsilon 4 allele appear to have an especially high risk of dementia. Positron-emission tomography (PET) has identified specific regions of the brain in which the rate of glucose metabolism declines progressively in patients with probable Alzheimer's disease. We used PET to investigate whether these same regions of the brain are affected in subjects homozygous for the epsilon 4 allele before the onset of cognitive impairment. Apolipoprotein E genotypes were established in 235 volunteers 50 to 65 years of age who reported a family history of probable Alzheimer's disease. Neurologic and psychiatric evaluations, a battery of neuropsychological tests, magnetic resonance imaging, and PET were performed in 11 epsilon 4 homozygotes and 22 controls without the epsilon 4 allele who were matched for sex, age, and level of education. An automated method was used to generate an aggregate surface-projection map that compared regional rates of glucose metabolism in the two groups. The epsilon 4 homozygotes were cognitively normal. They had significantly reduced rates of glucose metabolism in the same p...Continue Reading

References

Dec 31, 1976·Archiv für Psychiatrie und Nervenkrankheiten·A Brun, L Gustafson
Nov 1, 1975·Journal of Psychiatric Research·M F FolsteinP R McHugh
Nov 1, 1992·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·K J WorsleyP Neelin
Jan 1, 1991·Acta Neuropathologica·H Braak, E Braak
Feb 1, 1990·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·E G McGeerR Harrop
Jan 1, 1988·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·J DavignonC F Sing
Jun 1, 1987·Annals of Neurology·R D TerryL A Hansen
Mar 1, 1983·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·C S PatlakJ D Fenstermacher
Jan 1, 1982·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·D E KuhlM E Phelps
Nov 9, 1995·The New England Journal of Medicine·T PolvikoskiK Kontula
Oct 1, 1995·Archives of Neurology·R J CaselliM J Cevette
Mar 22, 1995·JAMA : the Journal of the American Medical Association·G W SmallL Chang
Sep 24, 1994·Lancet·S MinoshimaD E Kuhl
Dec 7, 1994·JAMA : the Journal of the American Medical Association·P W WilsonE J Schaefer
Nov 8, 1994·Proceedings of the National Academy of Sciences of the United States of America·W J StrittmatterA D Roses
Jan 1, 1994·Nature Genetics·F SchächterD Cohen
Sep 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·W J StrittmatterA D Roses
Oct 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·D E SchmechelA D Roses
Mar 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·W J StrittmatterA D Roses
Jan 1, 1993·Genetic Epidemiology·J A CauleyL H Kuller
Feb 1, 1960·Journal of Neurology, Neurosurgery, and Psychiatry·M HAMILTON

❮ Previous
Next ❯

Citations

Oct 3, 2007·Archives of General Psychiatry·Sterling C JohnsonMark A Sager
Sep 25, 2003·JAMA : the Journal of the American Medical Association·Nikolaos ScarmeasKaren E Anderson
Dec 30, 2003·BioFactors·M BattinoG P Littarru
Jan 1, 1997·New Directions for Mental Health Services·G Small
Jan 1, 2008·The Journal of Nutrition, Health & Aging·J R BarrioG Small
Jun 7, 2003·Annals of Nuclear Medicine·Karl Herholz
Jul 13, 2001·Annals of Nuclear Medicine·H Matsuda
Feb 21, 2003·Annals of Nuclear Medicine·Kazunari Ishii
Jul 3, 2004·European Journal of Nuclear Medicine and Molecular Imaging·Bich-Ngoc-Thanh TangThierry Vander Borght
Mar 5, 2005·European Journal of Nuclear Medicine and Molecular Imaging·Lisa Mosconi
Nov 12, 2005·European Journal of Nuclear Medicine and Molecular Imaging·Kazunari Ishii, Satoshi Minoshima
Feb 27, 2008·European Journal of Nuclear Medicine and Molecular Imaging·Marc WermkeAlexander Drzezga
Jan 26, 2008·European Journal of Nuclear Medicine and Molecular Imaging·A WinkelerA H Jacobs
Dec 17, 2009·Brain Structure & Function·Thomas Wisniewski, Allal Boutajangout
May 4, 2007·Neuropsychology Review·Christina E Wierenga, Mark W Bondi
Mar 14, 2007·Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging·Robert M Cohen
Jul 29, 2009·Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging·Liana G ApostolovaDaniel H Silverman
May 27, 2010·Brain Imaging and Behavior·Francesca M FilbeyRobert M Cohen
Mar 4, 2006·Current Psychiatry Reports·Nikolaos Scarmeas, Yaakov Stern
Mar 19, 2013·Neuroinformatics·Bo ChengUNKNOWN Alzheimer’s Disease Neuroimaging Initiative
Sep 6, 2002·Journal of Molecular Neuroscience : MN·Gary W Small
Jan 29, 2011·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Maria Carmela TartagliaBruce L Miller
Apr 15, 2004·Current Opinion in Neurobiology·Venkata S Mattay, Terry E Goldberg
Jun 18, 2005·Journal of the Neurological Sciences·Jose C MasdeuJavier Arbizu
Jun 1, 2005·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·K L BoundyC C Rowe
Jul 16, 2008·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Samuel T Henderson
Nov 15, 2000·Disease-a-month : DM·C DeCarli
May 29, 1999·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·M IacoboniG L Lenzi
Nov 6, 2002·Journal of the Neurological Sciences·A FrankP Barreiro
Nov 6, 2002·Journal of the Neurological Sciences·Andreas K Demetriades
Apr 11, 2003·Journal of the Neurological Sciences·Haruo HanyuKimihiko Abe

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: APOE

Apolipoprotein E (APOE) polymorphic alleles are major genetic risk factors for Alzheimer's disease. Discover the latest research on APOE and other genetic determinants of Alzheimer's disease here.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

Alzheimer's Disease: Neuroimaging

Neuroimaging can help identify pathological hallmarks of Alzheimer's disease (AD). Here is the latest research on neuroimaging modalities, including magnetic resonance imaging and positron emission tomography, in AD.